Insider · CIK 0001297260
Frank M Fischer
Files at NVRO (NEVRO CORP), NPCE (NeuroPace Inc). First filing -, latest -.
In brief
Frank M Fischer files SEC Form 4 as director at NVRO (NEVRO CORP), and also at NPCE (NeuroPace Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Frank M Fischer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 19, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,467 | $15.63 | $23k | 599,534 | Jun 22, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,890 | $0.00 | $0 | 598,067 | Jun 5, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,368 | $0.00 | $0 | 5,368 | Jun 5, 2026 |
| Mar 20, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,826 | $13.00 | $24k | 595,177 | Mar 23, 2026 |
| Dec 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,431 | $16.59 | $24k | 593,351 | Dec 23, 2025 |
| Sep 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,389 | $9.94 | $24k | 591,920 | Sep 22, 2025 |
| Jun 30, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +4,469 | $4.49 | $20k | 570,126 | Jun 24, 2025 |
| Sep 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,440 | $9.73 | $24k | 572,566 | Jun 24, 2025 |
| Dec 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,303 | $10.31 | $24k | 574,869 | Jun 24, 2025 |
| Mar 29, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,799 | $13.20 | $24k | 576,668 | Jun 24, 2025 |
| Jun 28, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +3,141 | $7.56 | $24k | 579,809 | Jun 24, 2025 |
| Sep 30, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +3,407 | $6.97 | $24k | 583,216 | Jun 24, 2025 |
| Dec 21, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,059 | $11.53 | $24k | 585,275 | Jun 24, 2025 |
| Mar 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,975 | $12.02 | $24k | 587,250 | Jun 24, 2025 |
| Jun 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,281 | $10.41 | $24k | 589,531 | Jun 24, 2025 |
| Jun 6, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (right to buy)derivative | +8,745 | $0.00 | $0 | 8,745 | Jun 9, 2025 |
| Dec 31, 2023 | NVRO NEVRO CORP | AGrant or award Common Stock | +778 | $0.00 | $0 | 56,341 | Jan 3, 2024 |
Questions about Frank M Fischer
Answered from the filings on this page, as of the latest one.
Is Frank M Fischer buying or selling?
Frank M Fischer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Frank M Fischer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frank M Fischer has 0.
Where does Frank M Fischer file Form 4?
Frank M Fischer has filed Form 4 at NVRO (NEVRO CORP); NPCE (NeuroPace Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.